Fundacion De La Comunitat Valenciana Para La Gestion Del Instituto De Investigacion Sanitaria Y Biomedica De Alicante
- Address
- Edificio Gris, Avenida Pintor Baeza 12, 03010 Alicante, Spain
Fundacion De La Comunitat Valenciana Para La Gestion Del Instituto De Investigacion Sanitaria Y Biomedica De Alicante
The Alicante Institute for Health and Biomedical Research (ISABIAL) is a distinguished Spanish research institution dedicated to advancing clinical research across multiple medical specialties. The center demonstrates expertise in both oncological and diagnostic imaging research, contributing to international collaborative efforts in treatment optimization and diagnostic innovation.
- Pediatric oncology with focus on relapsed acute lymphoblastic leukemia (ALL) treatment protocols
- Advanced diagnostic imaging including spectral CT technology and pulmonary angiography
- Pulmonary vascular disease diagnosis and imaging optimization
The institute participates in international multicenter studies, including trials with the International BFM Study Group investigating novel therapeutic combinations for high-risk relapsed ALL in children. Additionally, ISABIAL conducts cutting-edge research in contrast-enhanced CT imaging, exploring protocols to optimize diagnostic accuracy while minimizing contrast medium usage for conditions such as pulmonary thromboembolism. This dual focus on pediatric hematology-oncology and advanced diagnostic radiology reflects the center's commitment to improving patient outcomes through both therapeutic innovation and enhanced diagnostic precision.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Fundacion De La Comunitat Valenciana Para La Gestion Del Instituto De Investigacion Sanitaria Y Biomedica De Alicante
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparison of Reduced versus Standard Dose Iomeprol in Spectral CT for the Monitoring of Thoracic Neoplasms: A Randomized, Crossover, Non-Inferiority Trial | Fundacion De La Comunitat Valenciana Para La Gestion Del Instituto De Investigacion Sanitaria Y Biomedica De Alicante | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Iomeprol | 2 | Unknown | 2024-11-11 | 2024-11-11 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.